The board of BioGaia has nominated Margareta Hagman and Urban
Strindlöv as Executive Vice Presidents of the company as of April 1,
2010.
Margareta is responsible for accounting, finance and administration
whilst Urban is responsible for product development and special
projects.
Latest press releases from BioGaia:
2009-10-22 Interim report 1 January - 30 September 2009
2009-10-08 BioGaia agreement for Denmark
2009-09-18 BioGaia signs agreement for France
For additional information contact:
Peter Rothschild, President, telephone: +46 8 -555 293 00
Jan Annwall, Executive Vice President, telephone: +46 8-555 293 00
BioGaia is a biotechnology company that develops, markets and sells
probiotic products
with documented health benefits. The products are primarily based on
the lactic acid
bacterium Lactobacillus reuteri (Reuteri), which has probiotic,
health-enhancing effects.
The class B share of the Parent Company BioGaia AB is quoted on the
Small Cap list
of the NASDAQ OMX Nordic Exchange Stockholm.
www.biogaia.com
